Abstract
Arsenic is a known toxin and carcinogen that is present in industrial settings and in the environment. The mechanisms of disease initiation and progression are not fully understood. In the last a few years, there has been increasing evidence of the correlation between the generation of reactive oxygen species (ROS), DNA damage, tumor promotion, and arsenic exposure. This article summarizes the current literature on the arsenic mediated generation of ROS and reactive nitrogen species (RNS) in various biological systems. This article also discusses the role of ROS and RNS in arsenic-induced DNA damage and activation of oxidative sensitive gene expression.
Similar content being viewed by others
References
WHO: Environmental Health Criteria 224-Arsenic. International Programme on Chemical Safety, Geneva, 2001
Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE: Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104: 620–628, 1996
Tam GK, Charbonneau SM, Bryce F, Pomroy C, Sandi E: Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol Appl Pharmacol 50: 319–322, 1979
Foa V, Colombi A, Maroni M, Buratti M, Calzaferri G: The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci Total Environ 34: 241–259, 1984
Cullen WR, Reimer KJ: Arsenic speciation in the environment. Chem Rev 89: 713–764, 1989
Mandal BK, Ogra Y, Suzuki KT: Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14: 371–378, 2001
Vahter M, Concha G: Role of metabolism in arsenic toxicity. Pharm Toxicol 89: 1–5, 2001
Yamanaka K, Katsumata K, Ikuma K, Hasegawa A, Nakano M, Okada S: The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett 152: 79–85, 2000
Hughes MF, Del Razo LM, Kenyon EM: Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. Toxicology 143: 155–166, 2000
Li W, Wanibuchi H, Salim EI, Yamamoto S, Yoshida K, Endo G, Fukushima S: Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound. Cancer Lett 134: 29–36, 1998
Hayashi H, Kanisawa M, Yamanaka K, Ito T, Udaka N, Ohji H, Okudela K, Okada S, Kitamura H: Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett 125: 83–88, 1998
Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC: Induction of gene amplification by arsenic. Science 241: 79–81, 1988
Barrett JC, Lamb PW, Wang TC, Lee TC: Mechanisms of arsenic-induced cell transformation. Biol Trace Elem Res 21: 421–429, 1989
Vahter M, Envall J: In vivo reduction of arsenate in mice and rabbits. Environ Res 32: 14–24, 1983
Yamauchi H, Yamamura Y: Urinary inorganic arsenic and methylarsenic excretion following arsenate-rich seaweed ingestion. Sangyo Igaku — Jpn J Industrial Health 21: 47–54, 1979
Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ: Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153: 411–418, 2001
Smith AH, Goycolea M, Haque R, Biggs ML: Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147: 660–669, 1998
Steinmaus C, Moore L, Hopenhayn-Rich C, Biggs ML, Smith AH: Arsenic in drinking water and bladder cancer. Cancer Invest 18: 174–182, 2000
Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40: 453–463, 1968
Ferreccio C, Gonzalez Psych C, Milosavjlevic Stat V, Marshall Gredis G, Sancha AM: Lung cancer and arsenic exposure in drinking water: A case-control study in northern Chile. Cadernos de Saude Publica 14(Suppl 3): 193–198, 1998
Bates MN, Smith AH, Hopenhayn-Rich C: Arsenic ingestion and internal cancers: A review. Am J Epidemiol 135: 462–476, 1992
Bates MN, Smith AH, Cantor KP: Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141: 523–530, 1995
Schwartz RA: Arsenic and the skin. Int J Dermatol 36: 241–250, 1997
Yeh S: Skin cancer in chronic arsenicism. Human Pathol 4: 469–485, 1973
Blot WJ, Fraumeni JF Jr: Arsenical air pollution and lung cancer. Lancet 2: 142–144, 1975
Tseng CH, Chong CK, Chen CJ, Tai TY: Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120: 125–133, 1996
Tseng CH, Chong CK, Heng LT, Tseng CP, Tai TY: The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Res Clin Pract 50(suppl 2): S61–S64, 2000
Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH: Vascular effects of chronic arsenic exposure: A review. Epidemiol Rev 16: 184–209, 1994
Wiseman H: Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 313: 17–29, 1996
Imlay JA: Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240: 640–642, 1988
Iwama K, Nakajo S, Aiuchi T, Nakaya K: Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Inter J Cancer 92: 518–526, 2001
Lynn S, Gurr JR, Lai HT, Jan KY: NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 86: 514–519, 2000
Liu SX, Athar M, Lippai I, Waldren C, Hei TK: Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity. Proc Natl Acad Sci USA 98: 1643–1648, 2001
Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE: Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 27: 1405–1412, 1999
Corsini E, Asti L, Viviani B, Marinovich M, Galli CL: Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: Role of mitochondria. J Invest Dermatol 113: 760–765, 1999
Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S: Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94: 2102–2111, 1999
Wang TS, Kuo CF, Jan KY, Huang H: Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol 169: 256–268, 1996
Cantoni O: Cross-resistance to heavy metals in hydrogen peroxide-resistant CHO cell variants. Mutat Res 324: 1–6, 1994
Li Y: Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253: 295–299, 1998
Liu F, Jan KY: DNA damage in arsenite-and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med 28: 55–63, 2000
Yamanaka K, Mizol M, Kato K, Hasegawa A, Nakano M, Okada S: Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol Pharm Bull 24: 510–514, 2001
Yamanaka K, Hayashi H, Tachikawa M, Kato K, Hasegawa A, Oku N, Okada S: Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat Res 394: 95–101, 1997
Yamanaka K, Hasegawa A, Sawamura R, Okada S: Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol Appl Pharmacol 108: 205–213, 1991
Yamanaka K, Hoshino M, Okamoto M, Sawamura R, Hasegawa A, Okada S: Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem Biophys Res Commun 168: 58–64, 1990
Yamanaka K, Okada S: Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ Health Perspect 102(suppl 3): 37–40, 1994
Yamazaki I: ESR spin-trapping studies on the reaction of Fe2+ ions with H2O2-reactive species in oxygen toxicity in biology. J Biol Chem 265: 13589–13594, 1990
Ahmad S, Kitchin KT, Cullen WR: Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch Biochem Biophys 382: 195–202, 2000
Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderon-Aranda ES, Manno M, Albores A: Stress proteins induced by arsenic. Toxicol Appl Pharmacol 177: 132–148, 2001
Pi J, Kumagai Y, Sun G, Yamauchi H, Yoshida T, Iso H, Endo A, Yu L, Yuki K, Miyauchi T, Shimojo N: Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic Biol Med 28: 1137–1142, 2000
Christodoulides N: Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91: 2306–2309, 1995
de Vera ME: Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 24: 1238–1245, 1996
Wong HR: Expression of iNOS in cultured rat pulmonary artery smooth muscle cells is inhibited by the heat shock response. Am J Physiol 269: L843–L848, 1995
Lynn S, Shiung JN, Gurr JR, Jan KY: Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med 24: 442–449, 1998
Hahn SM: Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med 28: 953–958, 2000
Mordan LJ: Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis 14: 1555–1559, 1993
Bau DT: Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision. Carcinogenesis 22: 709–716, 2001
Dikalov S: Detection of superoxide radicals and peroxynitrite by 1-hydroxy-4-phosphonooxy-2,2,6,6-tetramethylpiperidine: Quantification of extracellular superoxide radicals formation. Biochem Biophys Res Commun 248: 211–215, 1998
Brazy PC, Balaban RS, Gullans SR, Mandel LJ, Dennis VW: Inhibition of renal metabolism. Relative effects of arsenate on sodium, phosphate, and glucose transport by the rabbit proximal tubule. J Clin Invest 66: 1211–1221, 1980
Noguchi N, Niki E: Chemistry of active oxygen species and antioxidant, in Antioxidant status, diet, nutrition, and health. In: A.M. Papas (ed). CRC Press: New York, 1999, pp 3–20
Wang TS, Shu YF, Liu YC, Jan KY, Huang H: Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology 121: 229–237, 1997
Nordenson I, Beckman L: Is the genotoxic effect of arsenic mediated by oxygen free radicals? Hum Hered 41: 71–73, 1991
Wang TS, Huang H: Active oxygen species are involved in the induction of micronuclei by arsenite in XRS-5 cells. Mutagenesis 9: 253–257, 1994
Lee T, Cho IC: Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch Toxicol 69: 498–504, 1995
Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A: Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61: 5432–5440, 2001
Chen YC, Lin-Shiau SY, Lin JK: Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177: 324–333, 1998
Tsai SH, Hsieh MS, Chen L, Liang YC, Lin JK, Lin SY: Suppression of Fas ligand expression on endothelial cells by arsenite through reactive oxygen species. Toxicol Lett 123: 11–19, 2001
Flora SJ: Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exper Pharm Physiol 26: 865–869, 1999
Nakamuro K, Sayato Y: Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mut Res 88: 73–80, 1981
Mouron SA, Golijow CD, Dulout FN: DNA damage by cadmium and arsenic salts assessed by the single cell gel electrophoresis assay. Mutat Res 498: 47–55, 2001
Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP: Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94: 10907–10912, 1997
Hartwig A, Groblinghoff UD, Beyersmann D, Natarajan AT, Filon R, Mullenders LH: Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 18: 399–405, 1997
Wang TC: Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite. Int J Rad Biol 66: 367–372, 1994
Lynn S, Lai HT, Gurr JR, Jan KY: Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis 12: 353–358, 1997
Lee-Chen SF, Gurr JR, Lin IB, Jan KY: Arsenite enhances DNA double-strand breaks and cell killing of methyl methanesulfonate-treated cells by inhibiting the excision of alkali-labile sites. Mutat Res 294: 21–28, 1993
Li JH, Rossman TG: Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nitrosourea. Biol Trace Elem Res 21: 373–381, 1989
Yih LH, Lee TC: Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res 60: 6346–6352, 2000
Lee-Chen SF: Differential effects of luminol, nickel, and arsenite on the rejoining of ultraviolet light and alkylation-induced DNA breaks. Environ Mol Mutagen 23: 116–120, 1994
Hartmann A, Speit G: Comparative investigations of the genotoxic effects of metals in the single cells gel (SCG) assay and the sister chromatid exchange (SCE) test. Environ Mol Mutagen 23: 299–305, 1994
Wang TS, Hsu TY, Chung CH, Wang AS, Bau DT, Jan KY: Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells. Free Radic Biol Med 31: 321–330, 2001
Dong JT, Luo XM: Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat Res 302: 97–102, 1993
Ramirez P, Del Razo LM, Gutierrez-Ruiz MC, Gonsebatt ME: Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line. Carcinogenesis 21: 701–706, 2000
Boulikas T: Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) AntiCancer Res 11: 489–527, 1991
Wanibuchi H, Hori T, Meenakshi V, Ichihara T, Yamamoto S, Yano Y, Otani S, Nakae D, Konishi Y, Fukushima S: Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: Association with elevated ornithine decarboxylase activity and formation of 8-hydroxy-deoxyguanosine in the liver. Jpn J Cancer Res 88: 1149–1154, 1997
Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S: Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2′-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem Biophys Res Commun 287: 66–70, 2001
Matsui M, Nishigori C, Toyokuni S, Takada J, Akaboshi M, Ishikawa M, Imamura S, Miyachi Y: The role of oxidative DNA damage in human arsenic carcinogenesis: Detection of 8-hydroxy-2′-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol 113: 26–31, 1999
Zaman K, Pardini RS: An insect model for assessing arsenic toxicity: Arsenic elevated glutathione content in the Musca domestica and Trichoplusia ni. Bull Environ Contamin Toxicol 55: 845–852, 1995
Maiti S, Chatterjee AK: Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Arch Toxicol 75: 531–537, 2001
Santra A, Maiti A, Das S, Lahiri S, Charkaborty SK, Mazumder DN: Hepatic damage caused by chronic arsenic toxicity in experimental animals. J Toxicol — Clin Toxicol 38: 395–405, 2000
Singh P, Sharma R: Effect of orpiment (As2S3) on cytochrome P-450, glutathione and lipid peroxide levels of rat liver. J Environ Path, Toxic Oncol 13: 199–203, 1994
Schinella GR, Tournier HA, Buschiazzo HO, de Buschiazzo PM: Effect of arsenic (V) on the antioxidant defense system: In vitro oxidation of rat plasma lipoprotein. Pharmacol Toxicol 79: 293–296, 1996
Wu MM, Chiou HY, Wang TW, Hsueh YM, Wang IH, Chen CJ, Lee TC: Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect 109: 1011–1017, 2001
Hsueh YM, Wu WL, Huang YL, Chiou HY, Tseng CH, Chen CJ: Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141: 249–257, 1998
Spear N: Effects of glutathione on Fenton reagent-dependent radical production and DNA oxidation. Arch Biochem Biophys 324: 111–116, 1995
Radabaugh TR, Aposhian HV: Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase. Chem Res Toxic 13: 26–30, 2000
Zakharyan RA, Aposhian HV: Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharm 154: 287–291, 1999
Tabacova S, Baird DD, Balabaeva L, Lolova D, Petrov I: Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area. Placenta 15, 873–881, 1994
Santra A, Maiti A, Chowdhury A, Mazumder DN: Oxidative stress in liver of mice exposed to arsenic-contaminated water. Indian J Gastroenter 19: 112–115, 2000
Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE: Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med 21: 783–790, 1996
Deneke SM: Induction of cystine transport in bovine pulmonary artery endothelial cells by sodium arsenite. Biochim Biophys Acta 1109: 127–131, 1992
Mylona PV, Polidoros AN, Scandalios JG: Modulation of antioxidant responses by arsenic in maize. Free Radic Biol Med 25: 576–585, 1998
Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, Thomas DJ: Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14: 305–311, 2001
Lindner DJ: The interferon-beta and tamoxifen combination induces apoptosis using thioredoxin reductase. Biochim Biophys Acta 1496: 196–206, 2000
Powis G: The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 29: 312–322, 2000
Arner ES: Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102–6109, 2000
Baeuerle PA: Function and activation of NF-kappa B in the immune system. Ann Rev Immunol 12: 141–179, 1994
Ilnicka M: Antioxidants inhibit activation of transcription factors and cytokine gene transcription in monocytes. Ann NY Acad Sci 696: 396–398, 1993
Lee SW: Hydrogen peroxide primes promonocytic U937 cells to produce IL-1 beta. Ann NY Acad Sci 696: 399–401, 1993
Germolec DR, Spalding J, Boorman GA, Wilmer JL, Yoshida T, Simeonova PP, Bruccoleri A, Kayama F, Gaido K, Tennant R, Burleson F, Dong W, Lang RW, Luster MI: Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 386: 209–218, 1997
Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M: The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15: 6269–6279, 1996
Karin M: JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA 95: 9067–9069, 1998
Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X: Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276: 11414–11419, 2001
Tully DB, Collins BJ, Overstreet JD, Smith CS, Dinse GE, Mumtaz MM, Chapin RE: Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol Appl Pharm 168: 79–90, 2000
Kaltreider RC, Pesce CA, Ihnat MA, Lariviere JP, Hamilton JW: Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding. Mol Carcinogen 25: 219–229, 1999
Wijeweera JB, Gandolfi AJ, Parrish A, Lantz RC: Sodium arsenite enhances AP-1 and NFkappaB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol Sci 61: 283–294, 2001
Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI: Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60: 3445–3453, 2000
Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP: Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61: 314–320, 2001
Salazar AM, Ostrosky-Wegman P, Menendez D, Miranda E, Garcia-Carranca A, Rojas E: Induction of p53 protein expression by sodium arsenite. Mutat Res 381: 259–265, 1997
Vogt BL, Rossman TG: Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts — a possible mechanism for arsenite's comutagenicity. Mutat Res 478: 159–168, 2001
Zhang TC, Cao EH, Qin JF: Opposite biological effects of arsenic trioxide and arsacetin involve a different regulation of signaling in human gastric cancer MGC-803 cells. Pharmacology 64: 160–168, 2002
Ishitsuka K, Hanada S, Suzuki S, Utsunomiya A, Chyuman Y, Takeuchi S, Takeshita T, Shimotakahara S, Uozumi K, Makino T, Arima T: Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids. Br J Haemat 103: 721–728, 1998
Hamadeh HK, Vargas M, Lee E, Menzel DB: Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem Biophys Res Commun 263: 446–449, 1999
Lautier D: The role of poly(ADP-ribose) metabolism in response to active oxygen cytotoxicity. Biochim Biophys Acta 1221: 215–220, 1994
Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY, Karin M: Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem 275: 36062–36066, 2000
Barchowsky A, Roussel RR, Klei LR, James PE, Ganju N, Smith KR, Dudek EJ: Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxic Appl Pharm 159: 65–75, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shi, H., Shi, X. & Liu, K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 255, 67–78 (2004). https://doi.org/10.1023/B:MCBI.0000007262.26044.e8
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000007262.26044.e8